comparemela.com

Latest Breaking News On - Aufhauser - Page 8 : comparemela.com

STRATEC BIOMEDICAL SYSTEMS AG : Buy rating from Hauck & Aufhauser

In a research note published by Alexander Galitsa, Hauck & Aufhauser advises its customers to buy the stock. The target price is unchanged and still at EUR 87. | May 2, 2023

Hauck-aufhauser
Alexander-galitsa
Stratec-se-stock-exchange
News
Information
Press-release
N
Research
Vote
Published
Y

FIELMANN AG : Hauck & Aufhauser from Sell to Neutral

Hauck & Aufhauser readjusts its opinion and goes from selling to neutral on the stock. The target price is increased from EUR 25 to EUR 41. | April 28, 2023

Hauck-aufhauser
Fielmann-ag-stock-exchange
News
Information
Press-release
Mauck
Aufhauser
Readjusts
Its
Opinion
End

VERBIO AG : Hauck & Aufhauser remains its Buy rating

Tim Wunderlich from Hauck & Aufhauser retains his positive opinion on the stock with a Buy rating. The target price is reduced from EUR 105 to EUR 74. | April 28, 2023

Hauck-aufhauser
Tim-wunderlich
Verbio-vereinigte-bioenergie-ag-stock-exchange
News
Information
Press-release
Rim
Wunderlich
Rom
Mauck
Aufhauser

FLATEXDEGIRO : Hauck & Aufhauser remains its Buy rating

In a research note published by Simon Keller, Hauck & Aufhauser advises its customers to buy the stock. The target price is being increased from EUR 10 to EUR 11. | April 28, 2023

Hauck-aufhauser
Simon-keller
Flatexdegiro-ag-stock-exchange
News
Information
Press-release
N
Research
Vote
Published
Y

STRÖER : Hauck & Aufhauser keeps its Buy rating

Simon Keller from Hauck & Aufhauser retains his positive opinion on the stock with a Buy rating. The target price is still set at EUR 71. | April 28, 2023

Hauck-aufhauser
Simon-keller
News
Information
Press-release
Simon
Seller
Rom
Mauck
Aufhauser
Etains

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.